Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)

About the company

Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of oncology therapies. The company focuses on disabling cancer's ability to subvert immune attack by inhibiting adenosine in the tumor microenvironment and by blocking its production by tumors. Its product pipeline includes Adenosine A2A Receptor Antagonist CPI-444, Adenosine Production Inhibitor Anti-CD73, Adenosine A2B Receptor Antagonist, ITK Inhibitor, and Myeloid Cell Suppression. The company was founded by Richard A. Miller, Peter A. Thompson, and Joseph J. Buggy on January 27, 2014 and is headquartered in Burlingame, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

53

$NoneM

Total Revenue

53

Employees

$79.46M

Market Capitalization

-1.68

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 377376.69 82729.00 6.06 21.99 20.75
Merck & Co., Inc. MRK 202149.48 48081.00 7.59 19.94 21.10
Pfizer Inc. PFE 194670.90 50660.00 2.95 12.32 31.17
Eli Lilly & Co. LLY 153205.02 23087.00 51.99 27.00 23.97
AbbVie, Inc. ABBV 146737.92 34057.00 -23.49 17.50 24.65
Bristol Myers Squibb Co. BMY 110414.38 31006.00 2.68 93.87 3.08
Repligen Corp. RGEN 6456.09 286.00 6.19 281.31 8.11
Reata Pharmaceuticals, Inc. RETA 4978.60 20.00 23.58 -16.01 -150.30
Nektar Therapeutics NKTR 4220.48 137.00 3.29 -9.19 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3702.40 1.00 34.23 -5.66 None
Allakos, Inc. ALLK 3122.21 None 6.78 -33.38 None
Karuna Therapeutics, Inc. KRTX 2853.24 None 7.45 -70.35 None
ADC Therapeutics SA ADCT 2642.22 2.00 31.17 -22.65 None
OPKO Health, Inc. OPK 2289.84 891.00 1.63 -7.83 -32.92
Turning Point Therapeutics, Inc. TPTX 2259.00 None 6.80 -18.90 None
IGM Biosciences, Inc. IGMS 2244.09 None 9.89 -41.37 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1743.65 None 5.66 -27.97 None
Principia Biopharma, Inc. PRNB 1568.00 30.00 5.58 -22.31 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1551.78 None 9.51 -16.84 None
Zymeworks, Inc. ZYME 1511.16 26.00 3.14 -8.91 -629.37
Akcea Therapeutics, Inc. AKCA 1370.61 341.00 2.81 -48.72 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1305.15 None 6.76 -10.79 None
Tricida, Inc. TCDA 1301.44 None 6.69 -6.16 None
Arcutis Biotherapeutics, Inc. ARQT 1184.37 None 5.05 -18.94 None
Odonate Therapeutics, Inc. ODT 1150.14 None 9.42 -10.22 None
Phibro Animal Health Corp. PAHC 1072.15 818.00 5.41 29.06 4.49
Athenex, Inc. ATNX 1064.70 123.00 6.53 -9.89 -87.86
Akero Therapeutics, Inc. AKRO 957.58 None 8.00 -18.87 None
Constellation Pharmaceuticals, Inc. CNST 925.12 None 4.35 -9.97 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Gossamer Bio, Inc. GOSS 802.76 None 3.26 -4.04 None
Oric Pharmaceuticals, Inc. ORIC 800.80 None -8.69 -26.48 None
Phathom Pharmaceuticals, Inc. PHAT 789.50 None 4.38 -2.90 None
Aprea Therapeutics, Inc. APRE 769.86 None 6.81 -22.77 None
Quanterix Corp. QTRX 752.76 60.00 6.64 -17.21 -71.52
Krystal Biotech, Inc. KRYS 731.00 None 4.26 -35.25 None
Applied Therapeutics, Inc. APLT 690.14 14.00 4.46 -14.00 -19.41
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Keros Therapeutics, Inc. KROS 644.40 8.00 -29.11 -30.34 -285.35
Amneal Pharmaceuticals, Inc. AMRX 619.24 1679.00 4.26 -2.84 -11.85
Arcturus Therapeutics Holdings, Inc. ARCT 605.28 19.00 56.10 -21.76 -151.34
Oyster Point Pharma, Inc. OYST 596.40 None 5.99 -10.36 None
Mirum Pharmaceuticals, Inc. MIRM 503.75 None 3.28 -7.44 None
SIGA Technologies, Inc. SIGA 480.11 19.00 5.37 -24.40 -94.00
Satsuma Pharmaceuticals, Inc. STSA 463.25 None 4.56 -12.73 None
Imara, Inc. IMRA 461.21 None 4.45 -13.11 None
Biospecifics Technologies Corp. BSTC 436.94 40.00 3.55 18.69 61.80
DURECT Corp. DRRX 416.64 28.00 32.00 -17.23 -82.94
Crinetics Pharmaceuticals, Inc. CRNX 414.72 1.00 5.24 -7.11 -447.78
Fulcrum Therapeutics, Inc. FULC 410.55 1.00 6.92 -5.95 None
89bio, Inc. ETNB 386.40 None 4.77 -5.99 None
Relmada Therapeutics, Inc. RLMD 385.02 0.00 5.74 -32.17 -877.66
Ocular Therapeutix, Inc. OCUL 383.04 6.00 -46.94 -4.18 None
Kala Pharmaceuticals, Inc. KALA 380.16 6.00 4.16 -4.14 None
TCR2 Therapeutics, Inc. TCRR 373.20 None 2.55 -37.02 None
Osmotica Pharmaceuticals Plc OSMT 361.80 232.00 2.75 -1.32 -115.44
Ovid Therapeutics, Inc. OVID 324.90 None 7.68 -4.98 None
Urovant Sciences Ltd. UROV 301.80 None -5.35 -2.09 None
Aeglea Biotherapeutics, Inc. AGLE 298.98 4.00 9.44 -3.73 -523.27
HOOKIPA Pharma, Inc. HOOK 282.88 13.00 2.56 -6.25 -333.02
IDEAYA Biosciences, Inc. IDYA 274.60 None 4.17 -6.30 None
AMAG Pharmaceuticals, Inc. AMAG 273.70 321.00 1.05 -0.74 -115.05
Lannett Co., Inc. LCI 270.56 542.00 0.92 -8.90 -5.77
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Spero Therapeutics, Inc. SPRO 254.03 12.00 3.34 -3.12 -656.72
Gritstone Oncology, Inc. GRTS 236.88 4.00 2.12 -2.27 None
KalVista Pharmaceuticals, Inc. KALV 233.46 12.00 2.58 -7.21 -263.38
Kaleido Biosciences, Inc. KLDO 221.10 None 7.84 -3.02 None
Veru, Inc. VERU 211.90 39.00 7.09 -21.73 -25.53
LogicBio Therapeutics, Inc. LOGC 191.36 1.00 5.78 -4.50 None
Galera Therapeutics, Inc. GRTX 180.25 None 3.37 -2.74 None
Liquidia Technologies, Inc. LQDA 171.38 8.00 10.12 -3.48 -602.17
Sutro Biopharma, Inc. STRO 171.12 41.00 3.25 -2.81 -148.06
Avenue Therapeutics, Inc. ATXI 167.52 532.00 30.79 -11.51 26.69
Protara Therapeutics, Inc. TARA 166.14 None 2.50 -10.77 None
Evelo Biosciences, Inc. EVLO 160.96 None 4.12 -1.84 None
Evolus, Inc. EOLS 159.60 45.00 2.86 -1.57 -217.51
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
Tyme Technologies, Inc. TYME 148.35 None 8.60 -6.79 None
Trevi Therapeutics, Inc. TRVI 137.07 None 2.91 -4.67 None
scPharmaceuticals, Inc. SCPH 136.04 119.00 3.48 -4.34 -27.05
Harrow Health, Inc. HROW 135.72 51.00 8.70 -5.49 -47.54
Lyra Therapeutics, Inc. LYRA 134.40 1.00 -1.14 -8.06 -491.16
Aquestive Therapeutics, Inc. AQST 131.88 49.00 -7.60 -1.88 -139.64
PhaseBio Pharmaceuticals, Inc. PHAS 127.31 2.00 2.36 -2.66 None
Mustang Bio, Inc. MBIO 122.40 None 2.86 -2.49 None
TFF Pharmaceuticals, Inc. TFFP 121.60 None 4.71 -3.14 None
NeuBase Therapeutics, Inc. NBSE 121.24 None 50.94 -2.71 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
Ayala Pharmaceuticals, Inc. AYLA 116.40 3.00 -2.74 -5.64 -679.19
Eton Pharmaceuticals, Inc. ETON 99.36 1.00 10.82 -4.97 None
Milestone Pharmaceuticals, Inc. MIST 96.75 None 0.96 -1.55 None
Checkpoint Therapeutics, Inc. CKPT 79.60 2.00 6.86 -3.43 -949.53
Clearside Biomedical, Inc. CLSD 79.54 6.00 10.21 -4.51 -293.61
Corvus Pharmaceuticals, Inc. CRVS 79.46 None 1.27 -1.68 None
EyePoint Pharmaceuticals, Inc. EYPT 78.48 26.00 5.54 -1.60 -196.30
Xeris Pharmaceuticals, Inc. XERS 78.12 4.00 3.87 -0.60 None
Baudax Bio, Inc. BXRX 72.00 None -1.96 -1.03 None
Navidea Biopharmaceuticals, Inc. NAVB 68.34 1.00 -50.25 -6.18 -65.13
BiomX, Inc. PHGE 65.45 None 1.72 -1.53 None
Genprex, Inc. GNPX 59.85 None 5.08 -4.38 None
Assertio Therapeutics, Inc. ASRT 59.04 192.00 1.02 -0.36 -83.99
Aridis Pharmaceuticals, Inc. ARDS 56.97 1.00 -23.44 -1.95 -851.00
Aerpio Pharmaceuticals, Inc. ARPO 52.48 20.00 1.58 -2.78 -51.58
Menlo Therapeutics, Inc. MNLO 49.01 2.00 4.12 -0.52 -483.51
Eyenovia, Inc. EYEN 45.44 None 4.58 -2.22 None
Edesa Biotech, Inc. EDSA 44.82 0.00 6.38 -0.47 -395.23
Moleculin Biotech, Inc. MBRX 42.69 None 3.71 -4.64 None
Citius Pharmaceuticals, Inc. CTXR 36.45 None 2.70 -2.11 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Oncternal Therapeutics, Inc. ONCT 35.75 3.00 4.58 -1.42 -225.89
Mannatech, Inc. MTEX 34.80 156.00 1.47 7.84 3.45
AgeX Therapeutics, Inc. AGE 33.78 2.00 -44.45 -2.78 -658.11
Allena Pharmaceuticals, Inc. ALNA 33.70 None 4.44 -0.78 None
CNS Pharmaceuticals, Inc. CNSP 33.12 None 5.75 -6.09 None
Aileron Therapeutics, Inc. ALRN 32.48 None 4.46 -1.22 None
Adamis Pharmaceuticals Corp. ADMP 31.90 22.00 1.22 -1.08 -140.33
Acer Therapeutics, Inc. ACER 31.20 3.00 2.28 -1.20 -274.69
Annovis Bio, Inc. ANVS 26.88 None 2.46 -21.33 None
Millendo Therapeutics, Inc. MLND 25.80 0.00 0.61 -0.55 None
Hoth Therapeutics, Inc. HOTH 25.00 None 6.94 -2.78 None
Spring Bank Pharmaceuticals, Inc. SBPH 23.20 0.00 0.88 -0.89 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.81 1.00 8.25 -1.13 None
ProPhase Labs, Inc. PRPH 16.80 9.00 1.52 -5.60 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.21 5.00 -3.27 -0.45 -602.34
Adial Pharmaceuticals, Inc. ADIL 13.80 None 3.37 -1.82 None
Titan Pharmaceuticals, Inc. TTNP 12.00 4.00 5.00 -0.67 -437.91
PDS Biotechnology Corp. PDSB 11.69 None 1.29 -0.46 None
Novus Therapeutics, Inc. NVUS 7.39 None 0.63 -0.35 None
Brickell Biotech, Inc. BBI 5.05 5.00 1.66 -0.07 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

CRVS Corvus Pharmaceuticals, Inc. Common Stock

7d ago, source: Nasdaq

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Corvus Pharmaceuticals Inc

1mon ago, source: U.S. News & World Report

Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of oncology therapies. The company focuses on disabling cancer's ...

Corvus Pharmaceuticals to Present at the Jefferies 2020 Virtual Healthcare Conference

1mon ago, source: Business Insider

May 27, 2020 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted ...

Corvus Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update

23d ago, source: Bloomberg

Before it's here, it's on the Bloomberg Terminal.

Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock

24d ago, source: Bloomberg

Before it's here, it's on the Bloomberg Terminal.

Corvus Gold Provides Update on a Lower-Capex, Quick to Development Scenario

27d ago, source: wallstreet online

VANCOUVER, British Columbia, June 09, 2020 (GLOBE NEWSWIRE) -- Corvus Gold Inc. (“Corvus” or the “Company”) - (TSX: KOR, OTCQX: CORVF) announces an update on its ongoing detailed mining ...

Corvus Pharmaceuticals Inc.

14d ago, source: MarketWatch

03/29/2016 266,310 Derivative/Non-derivative trans. at $0 per share. 0 ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.